Who invested in Vaderis Therapeutics?
Vaderis Therapeutics, a Biotech & Pharma startup from Switzerland, raised USD 152 million in a Series B round announced on 11 August 2026. Investors: TCGX (lead), Life Sciences (lead), Goldman Sachs (lead), Omega Funds, Perceptive Advisors, Kalehua Capital, Medicxi, Droia Ventures and 2 more named in the source.
Vaderis Therapeutics
USD 152 millionSeries BBiotech & PharmaTCGXleadLife SciencesleadGoldman SachsleadOmega FundsPerceptive AdvisorsKalehua CapitalMedicxiDroia Ventures · +2 more in the source
Switzerlandprnewswire.com
Questions founders ask
- Who invested in Vaderis Therapeutics?
- TCGX, Life Sciences, Goldman Sachs, Omega Funds, Perceptive Advisors, Kalehua Capital, Medicxi and Droia Ventures invested in Vaderis Therapeutics's Series B round, announced on 11 August 2026 (source: prnewswire.com).
- Who led Vaderis Therapeutics's Series B round?
- TCGX, Life Sciences and Goldman Sachs, according to prnewswire.com.
- How much did Vaderis Therapeutics raise?
- USD 152 million in its Series B round, as reported by prnewswire.com.
Raising next? See which investors fit your round.
In 30 minutes you'll know which funds matter for your round.
Request accessRounds are read from public funding coverage and matched against our investor database. Every line links to the article it came from — that article, not this page, is the source. Amounts are quoted exactly as the article stated them; we do not convert currencies. Individual angel investors named in an article are not listed here.
Something wrong? Tell us what to correct and we will fix it. To be removed from Oka entirely, use /remove-me.